Serum from patients with systemic vasculitis induces alternatively activated macrophage M2c polarization

Clinical Immunology

Volumn 152, Issue 1-2, 2014, Pages 10-19

  Ohlsson, Susanne M ^a   Linge, Carl Petrus ^a   Gullstrand, Birgitta ^b   Lood, Christian ^a   Johansson, Åsa ^b   Ohlsson, Sophie ^a   Lundqvist, Andrea ^c   Bengtsson, Anders A ^a   Carlsson, Fredric ^c   Hellmark, Thomas ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c BioInvent International AB   (Sweden)

Author keywords

ANCA; IL 10; IL 12; Macrophage polarization; Macrophages; Systemic vasculitis

Indexed keywords

CELL SURFACE PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GRANULOMATOSIS WITH POLYANGIITIS; HUMAN; HUMAN CELL; MACROPHAGE; MACROPHAGE ACTIVATION; MICROSCOPIC POLYANGIITIS; PHAGOCYTOSIS; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERUM; SYSTEMIC VASCULITIS; VASCULITIS;

ANCA; IL-10; IL-12; MACROPHAGE POLARIZATION; MACROPHAGES; SYSTEMIC VASCULITIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; APOPTOSIS; AUTOIMMUNITY; CELL DIFFERENTIATION; CELL LINE; CELL POLARITY; CYTOKINES; GLUCOCORTICOIDS; HUMANS; JURKAT CELLS; MACROPHAGE ACTIVATION; MACROPHAGES; NEUTROPHILS; PHAGOCYTOSIS; PHENOTYPE; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; SYSTEMIC VASCULITIS;

EID: 84897005856     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2014.02.016     Document Type: Article

References (33)

1. Cartin-Ceba R., Peikert T., Specks U. Pathogenesis of ANCA-associated vasculitis. Curr. Rheumatol. Rep. 2012, 14:481-493.
2. Kallenberg C.G. Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: where to go?. Clin. Exp. Immunol. 2011, 164(Suppl. 1):1-3.
3. Kettritz R. How anti-neutrophil cytoplasmic autoantibodies activate neutrophils. Clin. Exp. Immunol. 2012, 169:220-228.
4. Falk R.J., Terrell R.S., Charles L.A., Jennette J.C. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:4115-4119.
5. Xiao H., Schreiber A., Heeringa P., Falk R.J., Jennette J.C. Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies. Am. J. Pathol. 2007, 170:52-64.
6. Schreiber A., Xiao H., Jennette J.C., Schneider W., Luft F.C., Kettritz R. C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis. J. Am. Soc. Nephrol. 2009, 20:289-298.
7. Kessenbrock K., Krumbholz M., Schonermarck U., Back W., Gross W.L., Werb Z., Grone H.J., Brinkmann V., Jenne D.E. Netting neutrophils in autoimmune small-vessel vasculitis. Nat. Med. 2009, 15:623-625.
8. Xiao H., Heeringa P., Hu P., Liu Z., Zhao M., Aratani Y., Maeda N., Falk R.J., Jennette J.C. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J. Clin. Invest. 2002, 110:955-963.
9. Schreiber A., Xiao H., Falk R.J., Jennette J.C. Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies. J. Am. Soc. Nephrol. 2006, 17:3355-3364.
10. Little M.A., Smyth C.L., Yadav R., Ambrose L., Cook H.T., Nourshargh S., Pusey C.D. Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo. Blood 2005, 106:2050-2058.
11. Little M.A., Al-Ani B., Ren S., Al-Nuaimi H., Leite M., Alpers C.E., Savage C.O., Duffield J.S. Anti-proteinase 3 anti-neutrophil cytoplasm autoantibodies recapitulate systemic vasculitis in mice with a humanized immune system. PLoS One 2012, 7:e28626.
12. Ralston D.R., Marsh C.B., Lowe M.P., Wewers M.D. Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, alpha1-antitrypsin, and Fcgamma receptors. J. Clin. Invest. 1997, 100:1416-1424.
13. Hochreiter-Hufford A., Ravichandran K.S. Clearing the dead: apoptotic cell sensing, recognition, engulfment, and digestion. Cold Spring Harb. Perspect. Biol. 2013, 5:a008748.
14. Wickman G., Julian L., Olson M.F. How apoptotic cells aid in the removal of their own cold dead bodies. Cell Death Differ. 2012, 19:735-742.
15. Hong C., Kidani Y., A-Gonzalez N., Phung T., Ito A., Rong X., et al. Coordinate regulation of neutrophil homeostasis by liver X receptors in mice. J Clin Invest 2012 Jan 3, 122(1):337-347.
16. Korns D., Frasch S.C., Fernandez-Boyanapalli R., Henson P.M., Bratton D.L. Modulation of macrophage efferocytosis in inflammation. Front. Immunol. 2011, 2:57.
17. Nagata S., Hanayama R., Kawane K. Autoimmunity and the clearance of dead cells. Cell 2010, 140:619-630.
18. Aderem A., Underhill D.M. Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 1999, 17:593-623.
19. Birge R.B., Ucker D.S. Innate apoptotic immunity: the calming touch of death. Cell Death Differ. 2008, 15:1096-1102.
20. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. 2008, 8:958-969.
21. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004, 25:677-686.
22. Lu J., Cao Q., Zheng D., Sun Y., Wang C., Yu X., Wang Y., Lee V.W., Zheng G., Tan T.K., Wang X., Alexander S.I., Harris D.C., Wang Y. Discrete functions of M and M macrophage subsets determine their relative efficacy in treating chronic kidney disease. Kidney Int. 2013, 84:745-755.
23. Ohlsson S.M., Pettersson A., Ohlsson S., Selga D., Bengtsson A.A., Segelmark M., Hellmark T. Phagocytosis of apoptotic cells by macrophages in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis. Clin. Exp. Immunol. 2012, 170:47-56.
24. Wynn T.A., Chawla A., Pollard J.W. Macrophage biology in development, homeostasis and disease. Nature 2013, 496:445-455.
25. Lamprecht P. Off balance: T-cells in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides. Clin. Exp. Immunol. 2005, 141:201-210.
26. Zizzo G., Cohen P.L. IL-17 stimulates differentiation of human anti-inflammatory macrophages and phagocytosis of apoptotic neutrophils in response to IL-10 and glucocorticoids. J. Immunol. 2013, 190:5237-5246.
27. Ohlsson S., Wieslander J., Segelmark M. Circulating cytokine profile in anti-neutrophilic cytoplasmatic autoantibody-associated vasculitis: prediction of outcome?. Mediators Inflamm. 2004, 13:275-283.
28. Nogueira E., Hamour S., Sawant D., Henderson S., Mansfield N., Chavele K.M., Pusey C.D., Salama A.D. Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis. Nephrol. Dial. Transplant. 2010, 25:2209-2217.
29. Abdulahad W.H., Stegeman C.A., Limburg P.C., Kallenberg C.G. Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission. Arthritis Rheum. 2008, 58:2196-2205.
30. Goerdt S., Orfanos C.E. Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 1999, 10:137-142.
31. Wallet M.A., Flores R.R., Wang Y., Yi Z., Kroger C.J., Mathews C.E., Earp H.S., Matsushima G., Wang B., Tisch R. MerTK regulates thymic selection of autoreactive T cells. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:4810-4815.
32. Zizzo G., Hilliard B.A., Monestier M., Cohen P.L. Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction. J. Immunol. 2012, 189:3508-3520.
33. Abdgawad M., Pettersson A., Gunnarsson L., Bengtsson A.A., Geborek P., Nilsson L., Segelmark M., Hellmark T. Decreased neutrophil apoptosis in quiescent ANCA-associated systemic vasculitis. PLoS One 2012, 7:e32439.